Home

THOMAS L HARRISON

CIK 1247340 · Chrmn/CEO Divers. Agency Serv. · last filed 2026-07-07

THOMAS L HARRISON is a Chrmn/CEO Divers. Agency Serv. who has filed 54 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing shows the insider was granted $30.6K of AGEN on Jul 7, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.26M

Companies

11

Total Filings

54

Lifetime Open-Market Net

-$2.81M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGEN Director 47,545 $7.00 $332.8K $0 8 2026-07-07
ACXP Director — $1.53 — $0 4 2026-04-22
AFCG Director 24,539 $2.77 $68.0K $95.0K 6 2025-11-24
Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted Director 12,500 $1.30 $16.2K $175.0K 8 2018-06-07
SBH Director 0 $16.75 $0 -$187.1K 5 2017-12-11
PLx Pharma Inc. (PLXP) Delisted Director — $0.09 — $0 1 2017-04-20
Fifth Street Asset Management Inc. (FSAM) Delisted Director 6,000 — — $102.0K 4 2016-03-18
PLx Pharma Inc. (DPRX) Delisted Director 18,604 — — $24.0K 3 2016-01-21
EPOCRATES INC (EPOC) Delisted Director — — — $0 3 2013-03-13
Morgans Hotel Group Co. (MHGC) Delisted Director 41,269 — — $0 5 2012-05-21
OMC Chrmn/CEO Divers. Agency Serv. 199,149 $84.65 $16.86M -$3.02M 6 2010-03-31

Recent Filings

54 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 AGEN Grant (A) +8,547 $30.6K EDGAR
2026-04-28 AGEN Grant (A) — $0 EDGAR
2026-04-22 ACXP Grant (A) — $0 EDGAR
2026-04-13 AGEN Grant (A) +9,228 $30.6K EDGAR
2026-01-05 AGEN Grant (A) +7,691 $30.6K EDGAR
2025-11-24 AFCG Grant (A) +5,474 $15.0K EDGAR
2025-10-03 AGEN Grant (A) +5,780 $29.0K EDGAR
2025-07-15 AGEN Grant (A) +7,401 $25.6K EDGAR
2025-04-03 AGEN Grant (A) +8,898 $25.6K EDGAR
2025-02-27 AFCG Grant (A) +1,792 $15.0K EDGAR
Showing 1–10 of 54
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.